Advertisement

Neurocritical Care

, Volume 2, Issue 3, pp 274–281 | Cite as

Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement

  • Paul Vespa
  • David McArthur
  • Chad Miller
  • Kristine O’Phelan
  • John Frazee
  • Chelsea Kidwell
  • Jeffery Saver
  • Sidney Starkman
  • Neil Martin
Original Article

Abstract

Introduction: This ia a phase-2 safety trial to demonstrate the ability of frameless stereotactic aspiration and thrombolysis of ICH to safely remove blood.

Methods: Patients with ICH in the deep basal ganglia and internal capsule of >5 cc volume were consented to undergo computed tomographic imaging for frameless stereotactic guidance registration. Using the frameless stereotactic (CT) guidance, a 4-mm diameter catheter was inserted into the body of the hematoma using a frontal burr hole approach. The catheter was aspirated and then flushed with saline and aspirated to remove unclotted blood. After a confirmatory CT scan to localize the catheter, 1 mg of recombinant tissue plasminogen activator (t-PA) was infused into the clot, permitted to bathe the clot for 30 minutes, and then drained into a closed circuit collection system. t-PA was infused every 8 hours for 48 hours. A follow up CT scan was obtained at 48 hours.

Results: 28 patients with ICH (mean age 67.1) were admitted and underwent the procedure. Mean initial ICH volume was 54.6 cc ± 37.8. Mean time from onset to aspiration was 44 hours (range 7–180). Mean initial NIH Stroke scale (NIHSS) score was 24 (range 15–33). Compared with initial CT scan, there was a mean reduction of ICH volume by 77 ± 13% on final CT scan (p<0.0002). Compared with initial NIHSS, the discharge mean NIHSS (16 ± 6) was significantly improved (p<0.001). There were no infectious, hemodynamic or neurologic complications. There were no episodes of symptomatic hemorrhagic enlargement and one case of asymptomatic bleeding along the catheter tract.

Conclusion: Frameless stereotactic aspiration and thrombolysis (FAST) of deep spontaneous intracerebral hemorrhage is a safe therapy that is associated with reduction in ICH volume, early improvement in NIHSS and potentially could be used to improve outcome.

Key Words

Intracerebral hemorrhage surgery stereotactic stroke frameless guidance aspiration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Broderick J, Brott T, Tomsick T, et al. Intracerebral hemorrhage is more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993;78:188–191.PubMedGoogle Scholar
  2. 2.
    Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905–915.PubMedGoogle Scholar
  3. 3.
    Batjer HH, Reisch JS, Allern BC, et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage: a prospective randomized trial. Arch Neurol 1990;47:1103–1106.PubMedGoogle Scholar
  4. 4.
    Hankey GJ, Hon C. Surgery for primary intracerebral hemorrhage: Is it safer and effective? A systematic review of case series and randomized trials. Stroke 1997;28:2126–2132.PubMedGoogle Scholar
  5. 5.
    McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961;2:221–226.CrossRefGoogle Scholar
  6. 6.
    Juvela S, Heiskenan O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment. J Neurosurg. 1989;70:755–758.PubMedGoogle Scholar
  7. 7.
    Auer L, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989;70:530–535.PubMedGoogle Scholar
  8. 8.
    Hondo H. CT-guided stereotactic evacuation of hypertensive intracerebral hematomas. Tokushima J Exp Med 1983;30:25–39.PubMedGoogle Scholar
  9. 9.
    Mohadjer M, Eggert R, May J, et al. CT-guided stereotactic fibrinolysis of spontaneous and hypertensive cerebellar hemorrhage: long term results. J Neurosurg. 1990;73:217–222.PubMedGoogle Scholar
  10. 10.
    Morgenstern LB, Fankowski RF, Shedden P, et al. Surgical treatment for intracerebral hemorrhage (STICH): a single center randomized clinical trial. Neurology 1998;51:1359–1363.PubMedGoogle Scholar
  11. 11.
    Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.PubMedGoogle Scholar
  12. 12.
    Clasen RA, Huckman MS, Von Roenn KA, Pandolfi S, Laing I, Lobick JJ. A correlative study of computed tomography and histology in human and experimental vasogenic cerebral edema. J Comput Assist Tomogr 1981;5:313–327.PubMedCrossRefGoogle Scholar
  13. 13.
    Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891–897.PubMedGoogle Scholar
  14. 14.
    Rohde V, Rohde I, Thiex R, et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 2002;97:954–962.PubMedGoogle Scholar
  15. 15.
    Schwarz S, Jauss M, Krieger D, Dorfler A, Albert F, Hacke W. Haematoma evacuation does not improve outcome in spontaneous supratentorial intracerebral haemorrhage: a case-control study. Acta Neurochir (Wien) 1997;139(10):897–903.CrossRefGoogle Scholar
  16. 16.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005;365:387–397.PubMedGoogle Scholar
  17. 17.
    Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001 May 22;56(10):1294–1299.PubMedGoogle Scholar
  18. 18.
    Kanno T, Sano H, Shimoyima Y, et al. Role of surgery in hypertensive intracerebral hematoma: a comparative study of 305 nonsurgical and 154 surgical cases. Neurosurgery 1984;61:1091–1099.Google Scholar
  19. 19.
    Narayan RK, Narayan TM, Katz DA, et al. Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 1985;62:580–586.PubMedCrossRefGoogle Scholar
  20. 20.
    Kaufman HH, Schochet S, Koos W, et al. Efficacy and safety of tissue plasminogen activator. Neurosurgery 1987;20:403–407.PubMedCrossRefGoogle Scholar
  21. 21.
    Wagner K, Xi GH, Zuccarello, et al. Clot removal following lysis with tissue plasminogen activator markedly reduces perihematomal edema in an intracerebral hemorrhage model. Stroke 1996;27:183 (abstract).Google Scholar
  22. 22.
    Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999;30:1833–1839.PubMedGoogle Scholar
  23. 23.
    Montes JM, Wong JH, Fayad PB, Awad IA. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience. Stroke. 2000 Apr;31(4):834–840.PubMedGoogle Scholar
  24. 24.
    Schaller C, Rodhe V, Meyer B, et al. Stereotactive puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 1995;36:328–335.PubMedCrossRefGoogle Scholar
  25. 25.
    Lerch K, Schafer D, Uelzen J. Stereotactive evacuation and local fibrinolysis of spontaneous intracerebral hematomas. Adv Neurosurg 1993;21:93–99.Google Scholar
  26. 26.
    Niizuma H, Shimizu Y, Yonemitsu T, et al. Results of stereotactive apsiration in 175 cases of putaminal hemorrhage. Neurosrugery 1989;24:814–819.CrossRefGoogle Scholar
  27. 27.
    Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998;29:1573–1579.PubMedGoogle Scholar
  28. 28.
    Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intracentricular hemorrhage with urokinase: effects on 30 day survival. Stroke 2000;31:841–847.PubMedGoogle Scholar
  29. 29.
    Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1–5.PubMedGoogle Scholar
  30. 30.
    Fujii Y, Takeuchi S, Sasaki S, et al. Multivariate analysis of predictors of hematoma enlargement in spontaeous intracerebral hemorrhage. Stroke 1998;29:1160–1166.PubMedGoogle Scholar
  31. 31.
    Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370–2375.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  • Paul Vespa
    • 1
    • 2
  • David McArthur
    • 1
    • 2
  • Chad Miller
    • 1
    • 2
  • Kristine O’Phelan
    • 1
    • 2
  • John Frazee
    • 1
    • 2
  • Chelsea Kidwell
    • 1
    • 2
  • Jeffery Saver
    • 1
    • 2
  • Sidney Starkman
    • 1
    • 2
  • Neil Martin
    • 1
    • 2
  1. 1.David Geffen School of MedicineUniversity of CaliforniaLos Angeles
  2. 2.Division of Neurosurgery, Department of NeurologyUCLA Stroke Center, UCLA Brain Injury Research CenterUSA

Personalised recommendations